Assessment of Exercise Capacity in Children with Type 1 Diabetes in the Cooper Running Test.


Journal

International journal of sports medicine
ISSN: 1439-3964
Titre abrégé: Int J Sports Med
Pays: Germany
ID NLM: 8008349

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 18 12 2018
medline: 15 2 2019
entrez: 18 12 2018
Statut: ppublish

Résumé

Regular physical activity increases lifespan for those with type 1 diabetes. However, disease-related barriers may deter children from exercise and affect their fitness. This study examined the safety of the Cooper test concerning diabetes-related acute complications in children with type 1 diabetes and their fitness. Blood glucose was recorded before and 0, 30, 60 min after the test. The covered distances were transformed to z-scores based on the national charts. Body mass index, body fat percentage and glycated hemoglobin were measured. The run was completed by 80 individuals (45% boys, age 13.6±2.1 years; diabetes duration 6.3±3.5 years). During the follow-up 11 children reached glucose alert values (3-3.9 mmol/L), 3 presented clinically significant hypoglycemia (<3 mmol/L), none experienced severe hypoglycemia. The covered distance was 1914±298 m, not significantly different from the reference population (z-score -0.12±0.71 vs 0, p=0.12). The study participants were more overweight than general pediatric population in terms of body mass index (z-score 0.48±0.94 vs 0, p<0.001) and body fat percentage (z-score: 0.37±0.85 vs 0, p<0.001). In conclusion, the Cooper test can be safely used in children with diabetes to assess their physical capacity. Youth with type 1 diabetes present fitness similar to healthy children but exhibit increased body mass index and adiposity.

Identifiants

pubmed: 30557889
doi: 10.1055/a-0805-1326
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110-115

Informations de copyright

© Georg Thieme Verlag KG Stuttgart · New York.

Déclaration de conflit d'intérêts

None of the authors have a real or potential conflict of interest related to this study or manuscript.

Auteurs

Arkadiusz Michalak (A)

Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Lodz, Poland.

Andrzej Gawrecki (A)

Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland.

Szymon Gałczyński (S)

The Academic Laboratory of Movement and Human Physical Performance "DynamoLab", Lodz, Poland.

Jędrzej Nowaczyk (J)

Department of Pediatrics and Endocrinology, Warszawski Uniwersytet Medyczny, Warszawa, Poland.

Beata Mianowska (B)

Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Lodz, Poland.

Dorota Zozulinska-Ziolkiewicz (D)

Department of Internal Medicine and Diabetology, Poznan University of Medical Sciences, Poznan, Poland.

Agnieszka Szadkowska (A)

Department of Pediatrics, Diabetology, Endocrinology and Nephrology, Medical University of Lodz, Lodz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH